Zodiac: A Comprehensive Depiction of Genetic Interactions in Cancer by Integrating TCGA Data

Journal of the National Cancer Institute

Volumn 107, Issue 8, 2015, Pages

  Zhu, Yitan ^a   Xu, Yanxun ^b   Helseth, Donald L ^a   Gulukota, Kamalakar ^a   Yang, Shengjie ^a   Pesce, Lorenzo L ^c   Mitra, Riten ^d   Müller, Peter ^b   Sengupta, Subhajit ^a   Guo, Wentian ^e   Silverstein, Jonathan C ^a   Foster, Ian ^c   Parsad, Nigel ^a   White, Kevin P ^c,f   Ji, Yuan ^a,f  

^a NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^c ARGONNE NATIONAL LABORATORY   (United States)

^d UNIVERSITY OF LOUISVILLE   (United States)

^e FUDAN UNIVERSITY   (China)

^f UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BAYESIAN LEARNING; DATA ANALYSIS; DATA BASE; DATA PROCESSING; EVOLUTION; GENE INTERACTION; GENOMICS; KNOWLEDGE; MODEL; MOLECULAR INTERACTION; NEOPLASM; PRIORITY JOURNAL; BAYES THEOREM; COMPUTER INTERFACE; COMPUTER PROGRAM; EPISTASIS; GENETIC DATABASE; GENETICS; HUMAN; INTERNET; PROCEDURES; STATISTICAL MODEL; TRENDS;

BAYES THEOREM; DATABASES, GENETIC; EPISTASIS, GENETIC; GENOMICS; HUMANS; INTERNET; LIKELIHOOD FUNCTIONS; NEOPLASMS; SOFTWARE; USER-COMPUTER INTERFACE;

EID: 84939421550     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djv129     Document Type: Article

References (42)

1. Barabási A-L, Gulbahce N, Loscalzo J. Network medicine: a network-based approach to human disease. Nat Rev Genet. 2011;12(1):56-68.
2. Creixell P, Schoof E, Erler J, et al. Navigating cancer network attractors for tumor-specific therapy. Nat Biotechnol. 2012;30(9):842-848.
3. Cancer Target Discovery Development Network. Towards patient-based cancer therapeutics. Nat Biotechnol. 2010;28(9):904-906.
4. Chiang GG, Abraham RT. Targeting the mTOR signaling network in cancer. Trends Mol Med. 2007;13(10):433-442.
5. Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008;455(7216):1061-1068.
6. Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.
7. Omberg L, Ellrott K, Yuan Y, et al. Enabling transparent and collaborative computational analysis of 12 tumor types within The Cancer Genome Atlas. Nat Genet. 2013;45(10):1121-1126.
8. Cancer Genome Atlas Research Network. The cancer genome atlas pan-cancer analysis project. Nat Genet. 2013;45(10):1113-1120.
9. Gao J, Aksoy B, Dogrusoz U, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013;6(269):pl1.
10. Lawrence MS, Stojanov P, Mermel CH, et al. Discovery and saturation analysis of cancer genes across 21 tumour types. Nature. 2014;505:495-501.
11. Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9(559).
12. Mitra R, Müller P, Liang S, et al. A Bayesian graphical model for ChIP-Seq data on histone modifications. J Am Stat Assoc. 2013;108(501):69-80.
13. Xu Y, Zhang J, Yuan Y, et al. A Bayesian graphical model for integrative analysis of TCGA data. In. IEEE Int Workshop Genomic Signal Process Stat. Washington, DC; 2012:135-138.
14. Franceschini A, Szklarczyk D, Frankild S, et al. STRING v9.1: protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res. 2013;41(Database issue):D808-D815.
15. Zhu Y, Qiu P, Ji Y. TCGA-Assembler: open-source software for retrieving and processing TCGA data. Nat Methods. 2014;11(6):599-600.
16. Supercomputer Beagle. http://beagle.ci.uchicago.edu. Accessed April 24, 2015.
17. Vandin F, Upfal E, Raphael B. De novo discovery of mutated driver pathways in cancer. Genome Res. 2012;22(2):375-385.
18. Vandin F, Upfal E, Raphael B. Algorithms for detecting significantly mutated pathways in cancer. J Comput Biol. 2011;18(3):507-522.
19. Cowell RG, Dawid AP, Lauritzen SL, et al. Probabilistic Networks and Expert Systems. In: Springer; 1999.
20. Nuzzo R. Scientific method: statistical errors. Nature 2014;506:150-152.
21. Wallace TA, Prueitt RL, Yi M, et al. Tumor immunobiological differences in prostate cancer between African-American and European-American men. Cancer Res. 2008;68(3):927-936.
22. Kanehisa M, Goto S, Sato Y, et al. KEGG for integration and interpretation of large-scale molecular data sets. Nucleic Acids Res. 2012;40(Database issue):D109-D114.
23. Jiang C, Xuan Z, Zhao F, et al. TRED: a transcriptional regulatory element database, new entries and other development. Nucleic Acids Res. 2007;35(Database issue):40.
24. Cao R, Zhang Y. The functions of E(Z)/EZH2-mediated methylation of lysine 27 in histone H3. Curr Opin Genet Dev. 2004;14(2):155-164.
25. Varambally S, Dhanasekaran S, Zhou M, et al. The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature. 2002;419(6907):624-629.
26. Yang X, Karuturi R, Sun F, et al. CDKN1C (p57) is a direct target of EZH2 and suppressed by multiple epigenetic mechanisms in breast cancer cells. PloS One. 2009;4(4):e5011.
27. Fujii S, Ito K, Ito Y, et al. Enhancer of zeste homologue 2 (EZH2) downregulates RUNX3 by increasing histone H3 methylation. J Biol Chem. 2008;283:17324-17332.
28. Jiang X, Tan J, Li J, et al. DACT3 is an epigenetic regulator of Wnt/beta-catenin signaling in colorectal cancer and is a therapeutic target of histone modifications. Cancer Cell. 2008;13(6):529-541.
29. Bracken A, Pasini D, Capra M, et al. EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer. EMBO J. 2003;22(20):5323-5335.
30. Wu Z, Zheng S, Li Z, et al. Polycomb protein EZH2 regulates E2F1-dependent apoptosis through epigenetically modulating Bim expression. Cell Death Differ. 2010;17(5):801-810.
31. Kogure M, Takawa M, Saloura V, et al. The oncogenic polycomb histone methyltransferase EZH2 methylates lysine 120 on histone H2B and competes ubiquitination. Neoplasia. 2013;15(11):1251-1261.
32. Helin K. Regulation of cell proliferation by the E2F transcription factors. Curr Opin Genet Dev. 1998;8(1):28-35.
33. Trimarchi J, Lees J. Sibling rivalry in the E2F family. Nat Rev Mol Cell Biol. 2002;3(1):11-20.
34. Krzywinski M, Schein J, Birol I, et al. Circos: an information aesthetic for comparative genomics. Genome Res. 2009;19(9):1639-1645.
35. Cline MS, Craft B, Swatloski T, et al. Exploring TCGA pan-cancer data at the UCSC cancer genomics browser. Sci Rep. 2013;3:2652.
36. Cline MS, Smoot M, Cerami E, et al. Integration of biological networks and gene expression data using Cytoscape. Nat Protoc. 2007;2(10):2366-2382.
37. Akulenko R, Helms V. DNA co-methylation analysis suggests novel functional associations between gene pairs in breast cancer samples. Hum Mol Genet. 2013;22(15):3016-3022.
38. Tamborero D, Gonzalez-Perez A, Perez-Llamas C, et al. Comprehensive identification of mutational cancer driver genes across 12 tumor types. Sci Rep. 2013;3:2650.
39. Hofree M, Shen J, Carter H, et al. Network-based stratification of tumor mutations. Nat Methods. 2013;10(11):1108-1115.
40. Cerami E, Gross B, Demir E, et al. Pathway Commons, a web resource for biological pathway data. Nucleic Acids Res. 2011;39(Database issue):D685-f.
41. rd ed: Chapman and Hall/CRC; 2008.
42. Zhang B, Wang J, Wang X, et al. Proteogenomic characterization of human colon and rectal cancer. Nature. 2014;513:382-387.